SEOUL, South Korea, May 20, 2021 /PRNewswire/ — Johnson & Johnson Medical Korea Ltd. and Johnson & Johnson Innovation LLC immediately introduced the launch of the Seoul Innovation QuickFire Challenge on Smart Surgery in collaboration with the Seoul Metropolitan Government (SMG) and the Korea Health Industry Development Institute (KHIDI). The problem invitations innovators to submit probably ground-breaking concepts that intention to remodel the surgical pathway. Specific areas of curiosity embrace:

  • Potential digital options that intention to assist OR rework surgical pathway/ data-driven selections (earlier than/throughout/after surgical procedure)
  • Smart analysis and early intervention in cardiovascular and neurovascular areas
  • Infection management throughout and after surgical procedure
  • Potential biotech options aiming to enhance post-op restoration
  • Improved surgical planning and final result utilizing next-gen expertise (together with however not restricted to superior imaging and augmented actuality)

Awardee(s) will obtain grant funding from a complete of as much as KRW150,000,0001 (roughly US$134,0002), one yr of residency on the Seoul Bio Hub and entry to the Johnson & Johnson Innovation Asia Pacific ecosystem, together with a devoted workstation for one yr at JLABS @ Shanghai, and mentorship from consultants throughout the Johnson & Johnson Family of Companies.

The QuickFire Challenge goals to advance breakthrough improvements by combining Johnson & Johnson Innovation’s distinctive imaginative and prescient for collaboration in an open innovation mannequin with the Seoul Metropolitan Government’s efforts to drive innovation and commercialize its analysis outcomes; KHIDI’s skilled and systems-building help; and the Seoul Bio Hub’s skill to assist speed up the event and commercialization of potential early-stage, life-science options.

“Over the last few years, the Asia Pacific region has seen significant growth in the surgical robotics procedures market. We are committed to maintaining this momentum by identifying and nurturing technological advancements that could help remove current limitations in the surgical pathway,” mentioned Jae Yoo, Area Managing Director, North Asia for Johnson & Johnson Medical Devices Companies.3

JLABS @ Shanghai, a state-of-the artwork 4,400 square-meter healthcare incubator, is the primary Johnson & Johnson Innovation – JLABS location established in Asia Pacific to serve the better area.

Johnson & Johnson Innovation has developed the QuickFire Challenge platform with the intention to allow potential groundbreaking science and well being options by encouraging college students, entrepreneurs, researchers and start-up firms to deal with some of the world’s most difficult issues in healthcare.

This announcement marks the fifth QuickFire Challenge in Korea, following the launch of the earlier Seoul Innovation QuickFire Challenges in August 2017, August 2018, July 2019, and June 2020.

The deadline to use is July 9, 2021. For extra details about the Seoul Innovation QuickFire Challenge on Smart Surgery (together with the phrases and situations of entry), please go to: http://jji.jnj/smart-surgery.  

About Johnson & Johnson Innovation

Johnson & Johnson Innovation LLC works throughout the pharmaceutical, medical system and client well being sectors to speed up early-stage, transformational options by catalyzing the very best concepts, wherever they’re in the world. We do that by harnessing our deep scientific capabilities coupled with a variety of instruments, together with custom-made deal constructions, firm creation, incubation and startup providers, capital investments and different progressive enterprise fashions that intention to satisfy the various wants of entrepreneurs, scientists and rising firms. Our objective is to assist life science and well being expertise improvements thrive by way of collaboration and partnership with the worldwide ecosystem, in order that collectively we will change the trajectory of human well being. Meet our passionate crew of science and expertise consultants and learn to collaborate with us at www.jnjinnovation.com.

한국존슨앤드존슨메디칼 주식회사(Johnson & Johnson Medical Korea Ltd.)

한국존슨앤드존슨메디칼 주식회사는 존슨앤드존슨 의료기기 부문의 한국 법인이며, 더 많은 환자를 돕고 생명을 구하는 것을 목표로 하고 있다. 혈관질환 치료기구, 수술용 봉합사, 인공관절, 여성질환 전문치료기구, 내시경 수술기구, 자동 봉합기 등 다양한 제품을 공급한다. 전 세계 보건의료 분야에 임상 및 경제적 가치를 더하기 위하여 혁신적인 신제품을 제공하고, 차별화된 마케팅 전략과 우수한 품질관리 과정을 통해 고객 만족도를 높이고 있다.

About Johnson & Johnson Medical Devices Companies
As the world’s most complete medical gadgets enterprise, we’re constructing on a century of expertise, leveraging science and expertise, to form the long run of well being care. With unparalleled breadth, depth and attain in surgical procedure, orthopaedics, imaginative and prescient and interventional options we’re working to profoundly change the best way care is delivered. We are in this for all times.

Cautions Concerning Forward-Looking Statements

This press launch incorporates “forward-looking statements” as outlined in the Private Securities Litigation Reform Act of 1995 associated to the launch of the Seoul Innovation QuickFire Challenge on Smart Surgery. The reader is cautioned to not rely on these forward-looking statements. These statements are primarily based on present expectations of future occasions. If underlying assumptions show inaccurate or recognized or unknown dangers or uncertainties materialize, precise outcomes might range materially from the expectations and projections of Johnson & Johnson Innovation LLC and Johnson & Johnson Medical Korea Ltd and/or Johnson & Johnson. Risks and uncertainties embrace, however usually are not restricted to: the potential that the anticipated advantages and alternatives associated to the collaboration might not be realized or might take longer to understand than anticipated; challenges inherent in new product growth, together with the uncertainty of scientific success and acquiring regulatory approvals; competitors, together with technological advances, new merchandise and patents attained by opponents; uncertainty of industrial success for brand new merchandise; the power of the corporate to efficiently execute strategic plans; impression of enterprise mixtures and divestitures; challenges to patents; modifications in conduct and spending patterns or monetary misery of purchasers of well being care merchandise and providers; and international well being care reforms and traits towards well being care price containment. An additional checklist and descriptions of these dangers, uncertainties and different elements may be discovered in Johnson & Johnson’s Annual Report on Form 10-Okay for the fiscal yr ended December 30, 2018, together with in the sections captioned “Cautionary Note Regarding Forward-Looking Statements” and “Item 1A. Risk Factors,” and in the corporate’s most not too long ago filed Quarterly Report on Form 10-Q, and the corporate’s subsequent filings with the Securities and Exchange Commission. Copies of these filings can be found on-line at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. The Johnson & Johnson Innovation LLC and Johnson & Johnson Medical Korea Ltd and/or Johnson & Johnson don’t undertake to replace any forward-looking assertion in consequence of new data or future occasions or developments.

1  KRW75,000,000 for every Awardee
2  Based on trade charge of 1 South Korean gained = 0.00089 US Dollars
3  Jae Yoo is the Representative Director of Johnson & Johnson Medical Korea Ltd.

SOURCE Johnson & Johnson Innovation

Related Links

https://www.jnjinnovation.com



Sources